Adverse Events in NMOSD Therapy

Neuromyelitis optica spectrum disorders (NMOSD) are rare neurologic autoimmune diseases that have a poor prognosis if left untreated. For many years, generic oral immunosuppressants and repurposed monoclonal antibodies that target the interleukin-6 pathway or B cells were the mainstays of drug treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Giglhuber, Katrin, Berthele, Achim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029040/
https://www.ncbi.nlm.nih.gov/pubmed/35456972
http://dx.doi.org/10.3390/ijms23084154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029040/
https://www.ncbi.nlm.nih.gov/pubmed/35456972
http://dx.doi.org/10.3390/ijms23084154

Ejemplares similares